Table 2.
Effectiveness and safety outcomes in treated patients from Latin America. Crude incidence rates.
|
Latin America (n = 376) |
|||
|---|---|---|---|
| Patients with event | Patient years |
Crude IR |
|
| per 100 PY (95% CI) | |||
| Stroke | 2 | 615 | 0.33 (0.04–1.17) |
| -Ischemic stroke | 1 | ||
| -Unknown type/uncertain classification | 1 | ||
| Major bleeding | 3 | 615 | 0.49 (0.10–1.42) |
| -Life-threatening | 2 | ||
| -Transfusion (2 + units of blood/red cells) | 2 | ||
| -Fall in haemoglobin of 2 g/dL | 2 | ||
| -Fatal bleeds | 2 | ||
| -Gastrointestinal | 3 | ||
| -Intracranial | 0 | ||
| Myocardial Infarction | 6 | 614 | 0.98 (0.36–2.13) |
| All-cause death | 25 | 615 | 4.06 (2.63–6.00) |
| -Vascular death | 8 | ||
| -Nonvascular death | 11 | ||
| -Unknown | 6 | ||
| Composite outcome (Stroke, systemic embolism, myocardial infarction, life-threatening bleed, vascular death) | 15 | 613 | 2.45 (1.37–4.03) |
Acronyms: CI-Confidence interval; IR-Incidence rate; PY-Patient-years.